Conclusion
The immunogenicity of insulin preparations is of both academic and clinical interest. The links between insulin antibodies and insulin allergy, some forms of insulin resistance and injection site lipoatrophy are well-established, but other more subtle metabolic effects require further examination. Contamination with impurities (e.g. proinsulin) has been a major factor in the immunogenicity of conventional bovine insulin preparations but the less frequent, although still detectable, immunogenicity of highly purified porcine and human preparations remains enigmatic. Further work is required to analyse the physico-chemical factors involved, while the genetic control of the immune response to insulin is of fundamental interest.
In order to facilitate comparative studies of different insulin preparations and data translation between different laboratories, it is essential that efforts be made to introduce some elements of standardisation in assay techniques, reporting of results and assessment of precision, accuracy and sensitivity. International collaborative laboratory studies have been successful in various other areas of clinical research relevant to diabetes, notably the series of HLA workshops [53] and comparisons of the radioimmunoassay and bioassay of insulin [54, 55] and the radioimmunoassay of C-peptide [56]. It is hoped that present efforts to achieve successful collaboration for insulin antibody determination will harmonise the diverse approaches to the problems which continue to surround the immunogenicity of insulin.
Article PDF
Similar content being viewed by others
References
Tuft L (1928) Insulin hypersensitiveness: immunological consideration and case reports. Am J Med Sci 176: 707–720
Banting FG, Franks WR, Gairns S (1938) Physiological studies in metrazole shock. VII. Anti-insulin activity of insulin treated patients. Am J Psychol 95: 562–564
Clutton RF, Harington CR, Yuill ME (1938) Studies in synthetic immunochemistry. II. Serological investigation of 0-β-glucosidotyrosyl derivatives of proteins. Biochem J 32: 1111–1118
Berson SA, Yalow RS, Bauman A, Rothschild MA, Newerly K (1956) Insulin I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects. J Clin Invest 35: 170–190
Berson SA, Yalow RS (1959) Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest 38: 1996–2016
Reeves WG (1980) Immunology of diabetes and insulin therapy. In: Thompson RA (ed) Recent advances in clinical immunology. Churchill Livingstone, London, New York, pp 183–220
Keck K (1981) Insulin as a tool for the study of immunological problems. In: Keck K, Erb P (eds) Basic and clinical aspects of immunity to insulin. De Gruyter, Berlin, pp 219–235
Arquilla ER, Finn J (1965) Genetic control of combining sites of insulin antibodies produced by guinea pigs. J Exp Med 122: 771–784
Keck K (1975) Ir-gene control of immunogenicity of insulin and A-chain loop as a carrier determinant. Nature 254: 78–79
Kapp JA, Strayer DS (1978) H-2 linked Ir gene control of antibody responses to porcine insulin. J Immunol 121: 978–982
Rosenthal AS (1978) Determinant selection and macrophage function in genetic control of the immune response. Immunol Rev 40: 136–152
Bertrams J, Jansen FK, Grüneklee D, Reis HE, Drost H, Beyer J, Gries FA, Kuwert E (1976) HLA antigens and immunoresponsiveness to insulin in insulin-dependent diabetes mellitus. Tissue Antigens 8: 13–19
Irvine WJ, DiMario U, Feek CM, Ting A, Morris PJ, Gray RS, Duncan LJP (1978) Insulin antibodies in relation to islet cell antibodies and HLA antigens in insulin-dependent (Type I) diabetes. J Clin Lab Immunol 1: 111–114
Schernthaner G, Ludwig H, Mayr WR (1979) Immunoglobulin G — insulin antibodies and immune region-associated alloantigens in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 48: 403–407
Sonksen PH (1977) The evolution of insulin treatment. Clinics Endocrinol Metab 6: 481–497
Reeves WG, Kelly U (1982) Insulin antibodies induced by bovine insulin therapy. Clin Exp Immunol 50: 163–170
Reeves WG, Allen BR, Tattersall RB (1980) Insulin-induced lipoatrophy: evidence for an immune pathogenesis. Br Med J 280: 1500–1503
Bolinger RE, Morris JH, McKnight FG, Diederich DA (1964) Disappearance of I131 labelled insulin from plasma as a guide to management of diabetes. N Engl J Med 270: 767–770
Kurtz AB, Daggett PR, Mustaffa BE, Nabarro JDN (1977) Effect of insulin antibodies on free and total plasma-insulin. Lancet 2: 56–58
Vaughan NJA, Matthews JA, Kurtz AB, Nabarro JDN (1983) The bioavailability of circulating antibody-bound insulin following insulin withdrawal in Type I (insulin-dependent) diabetes. Diabetologia 24: 355–358
Walford S, Allison SP, Reeves WG (1982) The effect of insulin antibodies on insulin dose and diabetic control. Diabetologia 22: 106–110
Turner MW (1983) The immunoglobulins. In: Holborow EJ, Reeves WG (eds) Immunology in medicine, 2nd ed. Academic Press, London, pp 35–58
Hildemann WH, Clark EA, Raison RL (1981) Comprehensive immunogenetics. Blackwell Scientific Publications, Oxford
Kilpatrick JM, Virella G (1980) Isolation and characterization of soluble insulin — anti-insulin immune complexes formed in vitro and in vivo in sera from patients with diabetes mellitus. Clin Exp Immunol 40: 445–452
Birkinshaw VJ, Randall SS, Risdall PC (1982) Formation of precipitin lines between insulin and anti-insulin serum produced in sheep and in guinea pigs. Nature 193: 1089–1090
Barcinski MA, Rosenthal AS (1977) Immune response gene control of determinant selection. J Exp Med 145: 726–742
Keck K, Jager K, Geiger R, Brandenburg D, Gattner HG (1980) Specificity of rabbit anti-insulin antibody. In: Brandenburg D, Wollmer A (eds). Insulin, chemistry, structure and function of insulin and related hormones. De Gruyter, Berlin, pp 611–617
Christiansen AaH (1973) Radioimmunoelectrophoresis in the determination of insulin binding to IgG. Methodological studies. Horm Metab Res 5: 147–154
Kurtz AB, Matthews JA, Mustaffa BE, Daggett PR, Nabarro JDN (1980) Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin. Diabetologia 18: 147–150
Reeves WG, Kelly U (1980) An immunochemical method for the quantitation of insulin antibodies. J Immunol Meth 34: 329–338
Sebriakova M, Little JA (1973) A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects. Diabetes 22: 30–40
Andersen OO, Brunfeldt K, Abildgard F (1972) A method for quantitative determination of insulin antibodies in human plasma. Acta Endocrinol 69: 195–208
Flynn SD, Keren DF, Torretti B, Dieterle RC, Grauds S (1981) Factors affecting enzyme-linked immunosorbent assay for insulin antibodies in serum. Clin Chem 27: 1753–1757
Nakagawa S, Saito N, Nakayama H, Sasaki T, Watanabe T, Aoki S (1978) Detection of IgE insulin antibody with radioallergosorbent test. Diabetologia 14: 33–38
Hamilton RG, Rendell M, Adkinson NF (1980) Serological analysis of human IgG and IgE anti-insulin antibodies by solid-phase radioimmunoassays. J Lab Clin Med 96: 1022–1036
Falholt K (1982) Determination of insulin specific IgE in serum of diabetic patients by solid-phase radioimmunoassay. Diabetologia 22: 254–257
Kumar D (1977) Anti-insulin IgE in diabetes. J Clin Endocrinol Metab 45: 1159–1164
Chantler S, Diment JA (1981) Current status of specific IgM antibody assays. In: Voller A (ed) Immunoassays for the 80's. MTP, Lancaster, pp 417–430
Zollinger WD, Boslego JW (1981) A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies. J Immunol Meth 46: 129–140
Baxter RC, Yue DK, Turtle JR (1976) Equilibrium binding studies of insulin antibodies in diabetes subjects. Clin Chem 22: 1089–1094
Kerp L, Kasemir H (1976) High and low affinity insulin antibodies. Acta Endocrinol (Suppl) 205: 211–222
Jacobsen C, Frich JR Steensgaard J (1982) Determination of affinity of monoclonal antibodies against human IgG. J Immunol Meth 50: 77–88
Schroer JA (1981) Hybridoma antibody recognition of the insulin molecule. In: Fellows R, Eisenbarth G (eds) Monoclonal antibodies in endocrine research. Raven Press. New York, pp 167–179
Steward MW (1981) The biological significance of antibody affinity. Immunology Today 2: 134–140
Yue DK, Baxter RC, Turtle JR (1976) The dissociation of insulin from human insulin antibodies. Biochim Biophys Acta 444: 231–239
Peacock I, Taylor A, Tattersall RB, Douglas CA, Reeves WG (1983) Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control. Lancet 1: 149–152
Yalow RS (1976) Application of radioimmunologic methods to problems in insulin antigenicity and hormonal assay. Acta Med Scand S601: 149–196
Jorgensen KH, Larsen UD (1980) Homogeneous mono-125I-insulins: preparation and characterization of mono-125I-(Tyr A14)-and mono-125I-(Tyr A19)-insulin. Diabetologia 19: 546–554
Linde S, Hansen B (1980) Monoiodoinsulin specifically substituted in TYR A14 or TYR A19. Int J Peptide Protein Res 15: 495–502
Markussen J, Larsen UD (1980) The application of HPLC to the analysis of radio-iodinated tracers of glucagon and insulin. In: Brandenburg D, Wollmer A (eds) Insulin, chemistry, structure and function of insulin and related hormones. De Gruyter, Berlin, pp 161–168
Aarden LA, Lakmaker F, Feltkamp TEW (1976) Immunology of DNA. I. The influence of reaction conditions on the Farr assay as used for the detection of anti-ds DNA. J Immunol Meth 10: 27–37
Yue DK, Baxter RC, Turtle JR (1978) C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus. Metabolism 27: 35–44
Terasaki PI (ed) (1980) Histocompatibility testing 1980. UCLA Tissue Typing Laboratory, Los Angeles
Cotes PM, Mussett MV, Berryman I, Ekins R, Glover S, Hales N, Hunter WM, Lowy C, Neville RWJ, Samols E, Woodward PM (1969) Collaborative study of estimates by radioimmunoassay of insulin concentrations in plasma samples examined in groups of five or six laboratories. J Endocrinol 45: 557–569
Bangham DR, de Jonge H, Noordwijk J van (1978) The collaborative assay of the European Pharmacopoeia biological reference preparation for insulin. J Biol Stand 6: 301–314
Caygill CPJ, Gaines Das RE, Bangham DR (1980) Use of common standard for comparison of insulin C-peptide measurements by different laboratories. Diabetologia 18: 197–204
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reeves, W.G. Insulin antibody determination: Theoretical and practical considerations. Diabetologia 24, 399–403 (1983). https://doi.org/10.1007/BF00257336
Issue Date:
DOI: https://doi.org/10.1007/BF00257336